Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Aegirbio signs agreement with Salofa for the veterinary market and receives a first order worth approximately SEK 2 million.

Aegirbio has signed a non-exclusive agreement with the Finnish company Salofa Oy. The agreement is for veterinary applications and gives Salofa access to AegirBio's instruments and MagnetoImmunoAssay (MIA) for its own development of tests in veterinary medicine.With this agreement, AegirBio will, via its subsidiary Magnasense Technologies OY, sell its existing MagniaReader to Salofa, which will bring it to market with proprietary tests for horses, dogs and cats. Magnasense receives revenue from the sale of instruments and royalties on the disposable products ie. tests that Salofa sells for

Wärtsilä’s Half year financial report January–June 2023 to be published 21 July 2023 at 8.30 EEST

Wärtsilä Corporation, Press release, 7 July 2023 at 11:00 EESTWärtsilä’s Half year financial report January–June 2023 to be published 21 July 2023 at 8.30 EEST Wärtsilä Corporation will publish its Half year financial report for the period January-June 2023 on Friday 21 July 2023 at 8.30 a.m. Finnish time. The report will be available in pdf-format on the company website at www.wartsila.com after publishing. A virtual analyst and press conference will be held as a webinar on the same day, Friday 21 July 2023, at 10.00 a.m. Finnish time (8.00 a.m. UK time).If you only wish to view

P CAPITAL ANNOUNCES NAV OF P CAPITAL PARTNERS IV

Press release Stockholm,7 July 2023   P Capital today announces that, at the close of business on 30 June 2023, the Net Asset Value, per participation loan debentures of P Capital Partners IV, is EUR 94.49 for series A1. Ordinary income of EUR 1.77 per series A1 participation loan debentures will be distributed to debenture holders on 21 July 2023. No repayment of capital will be distributed to debenture holders for the quarter. P Capital Partners IV’s assets are composed of 95.9 per cent privately issued corporate loans and 4.1 per cent publicly traded corporate bonds.

P CAPITAL ANNOUNCES NAV OF P CAPITAL PARTNERS IV B

Press release   Stockholm,7 July 2023     P Capital today announces that, at the close of business on 30 June 2023, the Net Asset Value per participation loan debentures of P Capital Partners IV B, is EUR 94.40 for series A1 and EUR 944.35 for series B. Ordinary income of EUR 1.63 per series A1 participation loan debentures and EUR 16.7 per series B participation loan debenture will be distributed on 21 July 2023. No repayment of capital will be distributed to debenture holders for the quarter. P Capital Partners IV B’s assets are composed of 95.9 per cent private high-

Desert Control AS – Purchase of shares by CEO

ISSUER DESERT CONTROL AS Sandnes, Norway, 7 July 2023:CEO of Desert Control AS ("Desert Control" or the "Company") has on 7 July 2023purchased shares in the company.On 7 July 2023, Ole Kristian Sivertsen, has through OKS Consulting AS purchased5000 shares in the Company at an average price of NOK 10.00.Following the transaction, OKS Consulting AS holds a total of 930 000 shares inthe Company.Primary insider notification pursuant to the market abuse regulation article 19are attached.For further information, please contact:Marianne Vika Bøe, Chief Financial Officer,

New technique fixes district heating leak

When Navirum Energi was hit by a district heating leak under the railway in Örebro Sweden, the solution was to reline the pipe. This is a new technique for district heating pipes, and FVB coordinated the project.The leak began in the early autumn at an unknown location under the railway in the centre of Örebro, where there are a number of other pipes in the ground. “It wasn't just a matter of digging and repairing the pipe or laying new pipes. We looked at various alternatives such as guided drilling and hammer drilling, but they would have been tricky because of the other pipes down

AskGamblers Casino Complaint Service: The Ultimate Mediation Solution for Players and iGaming Operators

July 7, 2023 - AskGamblers, the leading online casino website, is proud to present its revolutionary AskGamblers Casino Complaint Service (AGCCS). Established in July 2009, AGCCS has become the epitome of trust, efficiency, and excellence in the iGaming industry. With its unparalleled track record and exceptional features, AGCCS has not only secured its place as the go-to mediation service but has also become an integral part of players' folklore.AGCCS operates as the world's largest and fastest independent mediation service, facilitating seamless communication between players and iGaming

MyFirstApp Introduces Strategy and the Evolear System: An AI Model for Individual Learning

Stockholm, July 7, 2023MyFirstApp is introducing the company's strategy to provide customers and users with continuous educational development and effectiveness. As such, we are introducing our new strategic product: the development of the Evolear service. Evolear is a technical solution based on artificial intelligence (AI) that will become a central system within MyFirstApp and the Group's offerings.The goal of the company's product, Evolear, is to enhance the learning experience by providing personalized education. By using a developed, tailored, and trained AI-driven algorithm,

Fiskars to publish its Half-year Financial Report for January-June 2023 on July 20, 2023

Fiskars CorporationPress ReleaseJuly 7, 2023 at 10:30 a.m. EESTFiskars to publish its Half-year Financial Report for January-June 2023 on July 20, 2023 Fiskars Corporation will publish its Half-year Financial Report for January-June 2023 on July 20, 2023 at approximately 8:30 a.m. (EEST). The Half-Year Financial Report will be available on the company's website www.fiskarsgroup.com after publication.WebcastA webcast on the second quarter results will be held on July 20, 2023 at 11:00 a.m.(EEST). It will be held in English and can be followed at https://fiskars.videosync.fi/q2-

Enersense to deliver offshore steel structures to Aker Solutions in Norway

Enersense International PlcInvestor news 7 July 2023 at 10:30 a.mEnersense, a provider of zero-emission energy solutions, will deliver steel structures to Aker Solutions in Norway. Aker Solutions is involved in various offshore projects internationally. Aker Solutions has ordered steel structure modules (pre-assembled units) from Enersense for the Hugin A production platform which is part of the Aker BP-operated Yggdrasil oil and gas development in the North Sea. The order will be included in Enersense’s Smart Industry business area’s third quarter 2023 order book. “This is a new

Renowned hospitals in the US select WasteLog™ to deter drug diversion of controlled substances

Pharmacolog i Uppsala AB (publ) announces that WasteLog™, used for drug diversion prevention, has been installed at several renowned hospitals throughout the United States.Each year, medication errors in healthcare cause costs of over 10 billion dollars in the United States and Europe. Furthermore, thefts of controlled substances are a major problem in the American market and part of the opioid crisis, which overall results in damages with an estimated annual cost of 78.5 billion dollars. The DEA and other law enforcement agencies are increasingly investigating healthcare providers and

Gradientech presents QuickMIC® at FEMS 2023

Gradientech will display its ultra-rapid and precise diagnostic system QuickMIC® at the FEMS Congress of European Microbiologists in Hamburg, Germany 9-13 July 2023.FEMS 2023 is the biggest event in Europe dedicated to showcasing the latest development of microbiology and connect to microbiologist from all over the world. Established in 1974, FEMS is a diverse federation of 55 European learned societies that includes around 30,000 professionals who are committed to advancing microbiology for the benefit of society. “We are excited to participate and showcase our innovative QuickMIC

Invitation to presentation of Q2 2023 interim report for Alleima

Alleima will publish its second quarter financial results on Friday July 21, 2023, at approximately 11:30 am CEST.A webcast and conference call for investors, analysts and financial media will be hosted at 1:00 pm CEST on July 21, 2023. Göran Björkman, President and CEO, as well as Olof Bengtsson, CFO, will present and comment on the report. To join the webcast online, access the presentation and other related materials, please visit the website of Alleima www.alleima.com/investors. Dial-in details for the conference call —    Sweden: +46 (0) 8 5051 0031 —    UK: +44 (0) 207

Invitation to presentation of Orexo´s Q2 2023 Interim Report

Uppsala, Sweden – July 7, 2023 – As previously communicated Orexo will announce the Interim Report for the second quarter of 2023 on July 18 at 8 am CET. The same day at 3 pm, analysts, investors, and media are invited to attend a presentation where Nikolaj Sørensen, CEO, and Fredrik Järrsten, CFO, will present the latest development and host a Q&A. To attend via teleconference where you can ask questions verbally use this link: https://conference.financialhearings.com/teleconference/?id=5007950 When registered you will be provided phone numbers and a conference ID to access the

Valmet strengthens its Process Technologies and Services segments by acquiring Körber’s Business Area Tissue

Valmet Oyj’s press release July 7, 2023 at 10:00 a.m. EESTValmet has on July 7, 2023, entered into an agreement to acquire Körber Group’s Business Area Tissue. The Business Area Tissue specializes in innovative converting and packaging technologies and services for the tissue industry.   By combining the complementary offering and competences of Valmet and the acquired business, Valmet creates the markets’ widest technology, automation and services offering for the growing tissue industry covering the entire tissue value chain. Growth in tissue demand is driven by several favourable

Newsletter July 2023 - Our future in your hand

We are currently in the middle of a rights issue which runs until July 12th. Meanwhile, work is ongoing in the projects, which we would like to highlight and tell you more about. However, let's start with sharing information about the rights issue before diving deeper into the projects.As you have probably seen, right now our existence depends on the success of this rights issue. We hope that these tough times with a declining economic situation for our company and many others with us, and even for our country and its people, is coming to an end and that a brighter future is in sight.

Invitation to web presentation of Formpipe’s Q2 report 2023.

Formpipe will publish its interim report for the second quarter 2023 on Friday 14 July 2023 at 08:15 (CEST).The same day at 10:00 (CET), Formpipe’s President and CEO Christian Sundin will host a web presentation in English which is webcasted live on: http://www.formpipe.com/en/q12023, where it also will be available on demand shortly afterwards. Following the presentation, Christian Sundin, and Joakim Alfredson CFO, will be available to answer questions. The report and presentation will be available at: www.formpipe.com/en/investors/reports-and-presentations Welcome!

Deutsche Börse AG extends offer period

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.With reference to SimCorp A/S' (SimCorp or the Company) announcement of 25 May 2023 (no. 11/2023) regarding the publication of the offer document (the Offer Document) concerning the all-cash voluntary recommended public takeover offer to acquire all of the issued and outstanding shares (except treasury shares) in SimCorp made by Deutsche Börse AG (Deutsche Börse) (the Offer), Deutsche Börse has

Ratos company Presis Infra secures new contracts amounting to NOK 2.3 billion in the first half of 2023

During the first half of 2023, Ratos company Presis Infra, which specialises in the maintenance of critical infrastructure including ferry quay operation and maintenance, and rockfall protection in Norway and Sweden, was awarded new contracts amounting to NOK 2.3 billion. The contracts were signed with existing customers and with terms from 2023 to 2028.“We are delighted that Presis Infra’s performance in the first half of 2023 was so positive. Maintenance of critical infrastructure will play an important role in the future, and Presis Infra has what it takes to succeed and the expertise to

The Subscription Period in Realheart’s Rights Issue Ends Today

Press Release, July 7, 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY,  WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE FURTHER REGISTRATION OR ANY OTHER MEASURES. Today, July 7, 2023, is the last day to subscribe for units in Scandinavian Real Heart AB (publ)’s (“Realheart” or the “Company”) rights issue, which was

Michael Forss new CFO for Bioservo Technologies

Bioservo Technologies AB (publ) (Nasdaq First North: BIOS) today announces that the company has contracted Michael Forss as new interim CFO and member of the management team. Michael succeeds Madeleine Börjesson as CFO and will take up the position on July 7, 2023.Michael has a background as an auditor and partner at EY with long and valuable experience of public companies in an international environment. Since 2019, Michael works in his own consulting company with advice in financial accounting, reporting and business management. Bioservo would like to take the opportunity to thank

Episurf Medical’s first US VAC approval

Today, Episurf Medical (Nasdaq: EPIS B) announces the first approval for its Episealer® Patellofemoral System from a hospital Value Analysis Committee (VAC). Value analysis committees allow hospitals to make informed decisions regarding the selection of medical devices, technologies, and services within their facility. They review factors such as clinical efficacy, patient outcomes, safety, cost-effectiveness, and overall value proposition of the products and services under consideration. Approval from a hospital’s VAC is a near-mandatory step required by every hospital or hospital system

Tonje Wikstrøm Frislid appointed new Managing Director of Nobina Norway

Tonje Wikstrøm Frislid has been appointed new Managing Director of Nobina Norway and member of Nobina’s Group management. Her most recent position was as CEO of the Norwegian airline Flyr.Tonje has extensive experience in the airline industry from several senior positions. She also has experience from the public transport sector and held the role of Chief Operating Officer at a competitor to Nobina. “I am very happy to announce that we have appointed Tonje as new Managing Director of Nobina Norway, where she will replace Jan Volsdal. Tonje has all of the qualities we are looking for and

Taichung Veterans General Hospital selects RayStation

RaySearch Laboratories AB (publ) announces that SHI Industrial Equipment (Taiwan) Co., Ltd. (SIET) has placed an order for RayStation®* treatment planning system to be installed at Taichung Veterans General Hospital (TCVGH), Taichung, Taiwan. SIET is a subsidiary of Sumitomo Heavy Industries, Ltd. which is a proton therapy machine vendor.The order includes licenses for both proton and photon treatment as well as advanced functionality such as Multi Criteria Optimization (MCO) and dose calculation on CBCT images for proton treatment. TCVGH will use a Sumitomo proton therapy machine with

There are no items matching the current filter
There are no more items matching the current filter
Back to top